Cyclin Dependent Kinase 4/6 Inhibitor Palbociclib Synergizes with BCL2 Inhibitor Venetoclax in Experimental Models of Mantle Cell Lymphoma Without RB1 Deletion
Experimental hematology & oncology(2024)
Key words
Cyclin-dependent kinase (CDK) inhibitors,Palbociclib,BCL2,Venetoclax,RB1,Mantle cell lymphoma (MCL)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined